Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: PS2 Mutations
PS2 N141I

General Information

Transgene:  PS2 cDNA reverse transcribed from normal aged human brain

Mutation:    N141I missense mutation

Promoter:  chicken b-actin promoter

Coding region: EcoRI-BglII fragment subcloned into pCAGGS, joined to the cytomegalovirus immediate early enhancer sequence, the chicken  b-actin promoter, and the rabbit b-globin polyadenylation signal.

Mouse Strain:  C57BL/6 (B6)J or DBF1 fremales and B6N males

Phenotype

Neuropathological analysis:

Steady-state level of  human wild-type and mutant PS2 mRNA was five (mutant) to fifteen (wildtype) higher than that of the endogenous mouse PS2 mRNA.

Ab42 levels appeared to be increase steadily in the mutant PS2 transgenic mouse brains from 2 to 8 months of age, whereas there was only a small increase in wild-type transgenic mice between the age of 5 and 8 months. Similar age-dependent increase in the Ab42 levels as seen in the mutant Tg is also observed in nontransgenic mice.

The insoluble Ab levels were found to be higher than the soluble Ab levels, and the insoluble Ab42 levels were markedly increased in mutant PS2 transgenic mice.  

Behavioral:

N/A

Availability

Not commercially available.  
Contact Dr. Yasuo Ihara 
Department of Neuropathology
University of Tokyo
7-3-1 Hongo
Bunkyo-ku, Tokyo 113-0033
Japan
Tel: 81-3-5841-3541
Fax: 81-3-5800-6852
yihara@m.u-tokyo.ac.jp

Patents: None

Reference

Primary:

Oyama F, Sawamura N, Kobayashi K, Morishima-Kawashima M, Kuramochi T, Ito M, Tomita T, Maruyama K, Saido TC, Iwatsubo T, Capell A, Walter J, Grunberg J, Ueyama Y, Haass C, Ihara Y. Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. J Neurochem 1998 Jul;71(1):313-22. Abstract.

Associated:

Sawamura N, Morishima-Kawashima M, Waki H, Kobayashi K, Kuramochi T, Frosch MP, Ding K, Ito M, Kim TW, Tanzi RE, Oyama F, Tabira T, Ando S, Ihara Y. Mutant presenilin 2 transgenic mice. A large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of blycerophospholipids and sphingomyelin. J Biol Chem 2000 Sep 8;275(36):27901-8. Abstract.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad